Jane Street’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.21M Buy
12,800
+4,900
+62% +$909K ﹤0.01% 4893
2025
Q4
$1.58M Sell
7,900
-14,000
-64% -$2.54M ﹤0.01% 5255
2025
Q3
$3.43M Buy
21,900
+17,400
+387% +$2.76M ﹤0.01% 4008
2025
Q2
$683K Buy
4,500
+3,000
+200% +$400K ﹤0.01% 6352
2025
Q1
$226K Sell
1,500
-19,500
-93% -$3.27M ﹤0.01% 8272
2024
Q4
$3.88M Sell
21,000
-12,200
-37% -$2.35M ﹤0.01% 3033
2024
Q3
$6.54M Buy
+33,200
New +$6.9M ﹤0.01% 2437
2023
Q2
Sell
-96,600
Closed -$19.5M 8787
2023
Q1
$19.5M Buy
+96,600
New +$21.9M 0.01% 1028
2022
Q4
Sell
-1,100
Closed -$216K 9268
2022
Q3
$216K Sell
1,100
-800
-42% -$173K ﹤0.01% 8047
2022
Q2
$407K Buy
+1,900
New +$464K ﹤0.01% 7098
2022
Q1
Sell
-67,600
Closed -$25.5M 10374
2021
Q4
$25.5M Sell
67,600
-7,000
-9% -$2.72M 0.01% 1012
2021
Q3
$30.8M Buy
74,600
+7,600
+11% +$3.16M 0.01% 836
2021
Q2
$24.8M Buy
67,000
+37,400
+126% +$12.5M 0.01% 930
2021
Q1
$8.58M Buy
29,600
+28,100
+1,873% +$7.81M ﹤0.01% 1707
2020
Q4
$375K Sell
1,500
-12,700
-89% -$3.02M ﹤0.01% 6116
2020
Q3
$3.22M Sell
14,200
-60,700
-81% -$12.6M ﹤0.01% 2353
2020
Q2
$13.1M Buy
+74,900
New +$12M 0.01% 1006

Other funds holding CRL

Jane Street's CRL Position: Q1 2026 in Review

Jane Street increased its Charles River Laboratories (CRL) stake by 1.2% in Q1 2026, buying an estimated $4.63K and bringing the position to 2,034 shares worth $351K. The position accounts for ﹤0.01% of the portfolio, ranked #8872.

Jane Street first reported a position in CRL in Q2 2013 and has held it in 39 quarters since. The position peaked at $20.7M in Q1 2025. 558 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Jane Street held 2,034 shares of Charles River Laboratories worth $351K as of Q1 2026.
  • Jane Street bought 25 Charles River Laboratories shares in Q1 2026, an estimated $4.63K.
  • Charles River Laboratories made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #8872 holding.
  • Jane Street first reported a position in Charles River Laboratories in Q2 2013 and has held it in 39 quarters since.
  • Jane Street's Charles River Laboratories position peaked at $20.7M in Q1 2025.
  • 558 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.